Search

everythinglearnresearchcommunity

for

Search:↓

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Diphenylcyclopropenone (DPCP) is more effective than anthralin for treating resistant alopecia areata.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Paroxetine relieves pain by increasing allopregnanolone levels.

Tofacitinib may help treat severe hair loss, but more research is needed.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

Higher doses of prednisone and triamcinolone acetonide successfully treated 8 out of 10 alopecia totalis patients.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

Modified steroidal inhibitors showed promise in treating hormone-dependent cancers.

The document's conclusion cannot be provided because the document is not available or cannot be read.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

ATP helps prevent skin damage from vandetanib by reducing stress.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Some new progesterone derivatives are better at blocking testosterone conversion than a common drug.

The study found that different criteria led to different patient groups in the CombAT study compared to the MTOPS study.

Tofacitinib might be used to treat hair loss.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

Agalsidase alfa helps treat Fabry's disease but needs more research for long-term benefits.